The importance of testing PET-directed therapy in patients with Hodgkin lymphoma.
Measuring the rapidity of response by PET scan and changing the treatment regimen in slow responders may lead to an improved outcome. Ongoing studies addressing this possibility have the potential to answer this question and need to be supported.